The executive order was the largest action to date by the second Trump administration on prescription drug costs but experts said it will probably not cause significant overall price decreases except in upcoming Medicare Part D negotiations, according to a New York Times report.

A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing Medicare drug price negotiations, a move that would fix one of the drug

President Donald Trump has signed an executive order looking to modify the Inflation Reduction Act’s (IRA's) drug price negotiation program, among other policy shifts. | A new, healthcare-focused executive order from President Trump is wide-ranging and includes provisions on drug prices,